400-0755-639
联系微信客服
最新产品
三叶新科每月上新,持续为科研人员提供新颖性研究工具,助力科研创新与突破。
首页 最新产品
DM4-SMCC
目录号:SY-101306
DM4-SMCC, a non-cleavable drug-linker conjugate for antibody-drug conjugates (ADC), leverages the antitumor efficacy of DM4 (an antitubulin agent) through attachment with the SMCC linker, exhibiting antitumor activity[1].
¥2875.00
查看详情
DM1-MCC
目录号:SY-101305
DM1-MCC (MCC-DM1) 是一种具有 MCC 接头的抗癌药物 DM1。
¥4968.00
查看详情
MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin
目录号:SY-101304
MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (compound 21a), is a camptothecin payload which can be utilized in the synthesis of a camptothecin antibody-drug conjugate (ADC) by conjugation to a monoclonal antibody (mAb).
¥3726.00
查看详情
DBCO-PEG4-MMAF
目录号:SY-101303
DBCO-PEG4-MMAF is an antibody-drug conjugate (ADC) component that exhibits potent antitumor activity. It combines the tubulin polymerization inhibitor MMAF with a cleavable linker, DBCO-PEG4, to target cancer cells effectively.
¥1897.00
查看详情
MCC-DM1
目录号:SY-101302
MCC-DM1 is a drug-Linker Conjugates for ADC such ad Anti-CD22-MCC-DM1.
¥3128.00
查看详情
SC-VC-PAB-DM1
目录号:SY-101301
SC-VC-PAB-DM1 is a drug-linker conjugate utilized in Antibody-Drug Conjugates (ADC), featuring DM1 (Mertansine, a tubulin inhibitor) linked through the SC-VC-PAB[1] ADC linker to deliver potent antitumor activity.
¥7475.00
查看详情
MC-Val-Cit-PAB-Retapamulin
目录号:SY-101300
MC-Val-Cit-PAB-Retapamulin is a drug-linker conjugate for antibody-drug conjugates (ADC) that exhibits potent antitumor activity. This compound utilizes Retapamulin, a ribosome inhibitor, connected through the ADC linker MC-Val-Cit-PAB.
¥1208.00
查看详情
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br
目录号:SY-101299
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Br 作为一种Drug-linker conjugates for ADC,主要用于抗CD40抗体活性分子偶联物 (ADCs) 的合成, 充当反应试剂。
¥9775.00
查看详情
XMT-1519 conjugate-1
目录号:SY-101298
XMT-1519 conjugate-1(化合物31)是一种与HER-2单克隆抗体XMT-1519的连接体,应用于ADC合成以增强其抗肿瘤活力。
¥19665.00
查看详情